Table 2.
Availability of laboratory investigations, drugs and lifestyle modification support in public health facilities in three states of India, 2016
| Level of health facility | Tertiary | Secondary | Primary |
|---|---|---|---|
| Number of facilities visited | 5 | 8 | 17 |
| Laboratory investigations | |||
| Glucometer/blood glucose | 5 (100) | 8 (100) | 17 (100) |
| HbA1c | 5 (100) | 1 (12) | 0 (0) |
| Lipid screening | 5 (100) | 6 (75) | 0 (0) |
| Fundus examination | 5 (100) | 7 (88) | 0 (0) |
| Urine examination | 5 (100) | 8 (100) | 12 (71) |
| Foot care | 5 (100) | 6 (75) | 0 (0) |
| ECG | 5 (100) | 6 (75) | 0 (0) |
| Drugs | 0 (0) | ||
| Glimepiride | 5 (100) | 6 (75) | 8 (47) |
| Glybenclamide | 0 (0) | 5 (62) | 8 (47) |
| Glyclazide | 2 (40) | 2 (25) | 0 (0) |
| Metformin | 5 (100) | 7 (88) | 14 (82) |
| Gliptin | 3 (60) | 1 (12) | 0 (0) |
| Insulin | 5 (100) | 4 (50) | 0 (0) |
| Atenolol/Metoprolol | 5 (100) | 8 (100) | 15 (88) |
| Amlodipine | 5 (100) | 6 (75) | 13 (77) |
| Losartan | 2 (40) | 0 (0) | 0 (0) |
| Enalapril | 4 (80) | 1 (12) | 3 (18) |
| Atorvastatin | 5 (100) | 3 (38) | 0 (0) |
| Antidiabetic drugs given for how many days (range) | 10–30 | 7–30 | 7–30 |
| Lifestyle modification support | |||
| Dietary counselling | 5 (100) | 6 (75) | 0 (0) |
| Smoking cessation counselling | 2 (40) | 2 (25) | 0 (0) |
| Yoga/physiotherapy/exercise | 2 (40) | 2 (25) | 0 (0) |
| Patient education on complications and their prevention | 2 (40) | 1 (12) | 2 (12) |
Notes: Numbers indicate number of facilities; numbers within parentheses indicate percentage, denominator being total number of facilities visited in that category.
Abbreviations: ECG, electrocardiogram; ECHO, echocardiogram.